Perry B. Molinoff

Title
InstitutionMedical University of South Carolina
DepartmentNeuroscience
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Jordan R, Hallam TJ, Molinoff P, Spana C. Developing treatments for female sexual dysfunction. Clin Pharmacol Ther. 2011 Jan; 89(1):137-41. PMID: 21085115.
      Citations:    
    2. Pfaus JG, Shadiack A, Van Soest T, Tse M, Molinoff P. Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist. Proc Natl Acad Sci U S A. 2004 Jul 06; 101(27):10201-4. PMID: 15226502.
      Citations:    
    3. Rosen RC, Diamond LE, Earle DC, Shadiack AM, Molinoff PB. Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra. Int J Impot Res. 2004 Apr; 16(2):135-42. PMID: 14999221.
      Citations:    
    4. Diamond LE, Earle DC, Rosen RC, Willett MS, Molinoff PB. Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction. Int J Impot Res. 2004 Feb; 16(1):51-9. PMID: 14963471.
      Citations:    
    5. Nakai S, Hirose T, Uwahodo Y, Imaoka T, Okazaki H, Miwa T, Nakai M, Yamada S, Dunn B, Burris KD, Molinoff PB, Tottori K, Altar CA, Kikuchi T. Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone. Eur J Pharmacol. 2003 Jul 04; 472(1-2):89-97. PMID: 12860477.
      Citations:    
    6. Molinoff PB, Shadiack AM, Earle D, Diamond LE, Quon CY. PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Ann N Y Acad Sci. 2003 Jun; 994:96-102. PMID: 12851303.
      Citations:    
    7. Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, Yocca FD, Molinoff PB. Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther. 2002 Jul; 302(1):381-9. PMID: 12065741.
      Citations:    
    8. Molinoff PB. Common to both academia and industry: the challenge of discovery. An interview with Perry Molinoff. Mol Interv. 2001 Jun; 1(2):78-83. PMID: 14993327.
      Citations:    
    9. Gribkoff VK, Starrett JE, Dworetzky SI, Hewawasam P, Boissard CG, Cook DA, Frantz SW, Heman K, Hibbard JR, Huston K, Johnson G, Krishnan BS, Kinney GG, Lombardo LA, Meanwell NA, Molinoff PB, Myers RA, Moon SL, Ortiz A, Pajor L, Pieschl RL, Post-Munson DJ, Signor LJ, Srinivas N, Taber MT, Thalody G, Trojnacki JT, Wiener H, Yeleswaram K, Yeola SW. Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med. 2001 Apr; 7(4):471-7. PMID: 11283675.
      Citations:    
    10. Wohlpart KL, Molinoff PB. Characterization of 5-HT- and ionomycin-stimulated changes in levels of intracellular calcium and PI hydrolysis in P11 cells. Ann N Y Acad Sci. 1998 Dec 15; 861:240-1. PMID: 9928265.
      Citations:    
    11. Wohlpart KL, Molinoff PB. Regulation of levels of 5-HT2A receptor mRNA. Ann N Y Acad Sci. 1998 Dec 15; 861:128-35. PMID: 9928249.
      Citations:    
    12. Burris KD, Fausing SM, Molinoff PB. Regulation of D2 and D3 receptors in transfected cells by agonists and antagonists. Adv Pharmacol. 1998; 42:443-6. PMID: 9327934.
      Citations:    
    13. Cowen DS, Molinoff PB, Manning DR. 5-hydroxytryptamine1A receptor-mediated increases in receptor expression and activation of nuclear factor-kappaB in transfected Chinese hamster ovary cells. Mol Pharmacol. 1997 Aug; 52(2):221-6. PMID: 9271344.
      Citations:    
    14. Zhong J, Gribkoff VK, Molinoff PB. Use of subunit-specific antisense oligodeoxynucleotides to define developmental changes in the properties of N-methyl-D-aspartate receptors. Mol Pharmacol. 1996 Sep; 50(3):631-8. PMID: 8794904.
      Citations:    
    15. Boundy VA, Lu L, Molinoff PB. Differential coupling of rat D2 dopamine receptor isoforms expressed in Spodoptera frugiperda insect cells. J Pharmacol Exp Ther. 1996 Feb; 276(2):784-94. PMID: 8632351.
      Citations:    
    16. Ferry RC, Molinoff PB. Regulation of 5-HT2A receptor mRNA in P11 cells. Behav Brain Res. 1996; 73(1-2):187-91. PMID: 8788500.
      Citations:    
    17. Boundy VA, Pacheco MA, Guan W, Molinoff PB. Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells. Mol Pharmacol. 1995 Nov; 48(5):956-64. PMID: 7476927.
      Citations:    
    18. Butkerait P, Zheng Y, Hallak H, Graham TE, Miller HA, Burris KD, Molinoff PB, Manning DR. Expression of the human 5-hydroxytryptamine1A receptor in Sf9 cells. Reconstitution of a coupled phenotype by co-expression of mammalian G protein subunits. J Biol Chem. 1995 Aug 04; 270(31):18691-9. PMID: 7629202.
      Citations:    
    19. Burris KD, Pacheco MA, Filtz TM, Kung MP, Kung HF, Molinoff PB. Lack of discrimination by agonists for D2 and D3 dopamine receptors. Neuropsychopharmacology. 1995 Jul; 12(4):335-45. PMID: 7576010.
      Citations:    
    20. Zhong J, Carrozza DP, Williams K, Pritchett DB, Molinoff PB. Expression of mRNAs encoding subunits of the NMDA receptor in developing rat brain. J Neurochem. 1995 Feb; 64(2):531-9. PMID: 7830045.
      Citations:    
    21. Ferry RC, Unsworth CD, Artymyshyn RP, Molinoff PB. Regulation of mRNA encoding 5-HT2A receptors in P11 cells through a post-transcriptional mechanism requiring activation of protein kinase C. J Biol Chem. 1994 Dec 16; 269(50):31850-7. PMID: 7989358.
      Citations:    
    22. Filtz TM, Guan W, Artymyshyn RP, Facheco M, Ford C, Molinoff PB. Mechanisms of up-regulation of D2L dopamine receptors by agonists and antagonists in transfected HEK-293 cells. J Pharmacol Exp Ther. 1994 Dec; 271(3):1574-82. PMID: 7996471.
      Citations:    
    23. Kung MP, Chumpradit S, Frederick D, Garner S, Burris KD, Molinoff PB, Kung HF. Characterization of binding sites for [125I]R(+)trans-7-OH-PIPAT in rat brain. Naunyn Schmiedebergs Arch Pharmacol. 1994 Dec; 350(6):611-7. PMID: 7708118.
      Citations:    
    24. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR, Trendelenburg U. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev. 1994 Jun; 46(2):121-36. PMID: 7938162.
      Citations:    
    25. Zhong J, Russell SL, Pritchett DB, Molinoff PB, Williams K. Expression of mRNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons. Mol Pharmacol. 1994 May; 45(5):846-53. PMID: 8190101.
      Citations:    
    26. Williams K, Zappia AM, Pritchett DB, Shen YM, Molinoff PB. Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits. Mol Pharmacol. 1994 May; 45(5):803-9. PMID: 8190097.
      Citations:    
    27. Unsworth CD, Molinoff PB. Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells. J Pharmacol Exp Ther. 1994 Apr; 269(1):246-55. PMID: 8169832.
      Citations:    
    28. Burris KD, Filtz TM, Chumpradit S, Kung MP, Foulon C, Hensler JG, Kung HF, Molinoff PB. Characterization of [125I](R)-trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino] tetralin binding to dopamine D3 receptors in rat olfactory tubercle. J Pharmacol Exp Ther. 1994 Feb; 268(2):935-42. PMID: 8114008.
      Citations:    
    29. Molinoff PB, Williams K, Pritchett DB, Zhong J. Molecular pharmacology of NMDA receptors: modulatory role of NR2 subunits. Prog Brain Res. 1994; 100:39-45. PMID: 7938532.
      Citations:    
    30. Filtz TM, Artymyshyn RP, Guan W, Molinoff PB. Paradoxical regulation of dopamine receptors in transfected 293 cells. Mol Pharmacol. 1993 Aug; 44(2):371-9. PMID: 8102783.
      Citations:    
    31. Cohen JA, Baggott LA, Romano C, Arai M, Southerling TE, Young LH, Kozak CA, Molinoff PB, Greene MI. Characterization of a mouse beta 1-adrenergic receptor genomic clone. DNA Cell Biol. 1993 Jul-Aug; 12(6):537-47. PMID: 8392347.
      Citations:    
    32. Boundy VA, Luedtke RR, Molinoff PB. Development of polyclonal anti-D2 dopamine receptor antibodies to fusion proteins: inhibition of D2 receptor-G protein interaction. J Neurochem. 1993 Jun; 60(6):2181-91. PMID: 8098355.
      Citations:    
    33. Ferry RC, Unsworth CD, Molinoff PB. Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells. Mol Pharmacol. 1993 May; 43(5):726-33. PMID: 8388988.
      Citations:    
    34. Boundy VA, Luedtke RR, Artymyshyn RP, Filtz TM, Molinoff PB. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides. Mol Pharmacol. 1993 May; 43(5):666-76. PMID: 8502224.
      Citations:    
    35. Boundy VA, Luedtke RR, Gallitano AL, Smith JE, Filtz TM, Kallen RG, Molinoff PB. Expression and characterization of the rat D3 dopamine receptor: pharmacologic properties and development of antibodies. J Pharmacol Exp Ther. 1993 Feb; 264(2):1002-11. PMID: 8437101.
      Citations:    
    36. Williams K, Russell SL, Shen YM, Molinoff PB. Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro. Neuron. 1993 Feb; 10(2):267-78. PMID: 8439412.
      Citations:    
    37. Unsworth CD, Molinoff PB. Regulation of the 5-hydroxytryptamine1B receptor in opossum kidney cells after exposure to agonists. Mol Pharmacol. 1992 Sep; 42(3):464-70. PMID: 1328846.
      Citations:    
    38. Williams K, Pullan LM, Romano C, Powel RJ, Salama AI, Molinoff PB. An antagonist/partial agonist at the polyamine recognition site of the N-methyl-D-aspartate receptor that alters the properties of the glutamate recognition site. J Pharmacol Exp Ther. 1992 Aug; 262(2):539-44. PMID: 1354252.
      Citations:    
    39. Luedtke RR, Artymyshyn RP, Monks BR, Molinoff PB. Comparison of the expression, transcription and genomic organization of D2 dopamine receptors in outbred and inbred strains of rat. Brain Res. 1992 Jul 03; 584(1-2):45-54. PMID: 1355393.
      Citations:    
    40. Williams K, Dichter MA, Molinoff PB. Up-regulation of N-methyl-D-aspartate receptors on cultured cortical neurons after exposure to antagonists. Mol Pharmacol. 1992 Jul; 42(1):147-51. PMID: 1353248.
      Citations:    
    41. Romano C, Williams K, DePriest S, Seshadri R, Marshall GR, Israel M, Molinoff PB. Effects of mono-, di-, and triamines on the N-methyl-D-aspartate receptor complex: a model of the polyamine recognition site. Mol Pharmacol. 1992 Apr; 41(4):785-92. PMID: 1533270.
      Citations:    
    42. Ebersole BJ, Molinoff PB. Identification of ascorbate as an endogenous substance that irreversibly inhibits binding of dihydropyridine calcium channel blockers. J Neurochem. 1992 Apr; 58(4):1300-7. PMID: 1532195.
      Citations:    
    43. Gonzales JM, O'Donnell JK, Stadel JM, Sweet RW, Molinoff PB. Down-regulation of beta-adrenergic receptors by pindolol in Gs alpha-transfected S49 cyc- murine lymphoma cells. J Neurochem. 1992 Mar; 58(3):1093-1103. PMID: 1310718.
      Citations:    
    44. Artymyshyn RP, Ivins KJ, Monks BR, Luedtke RR, Molinoff PB. Quantitation of isotypes of D2 receptors using solution hybridization. Neurochem Int. 1992 Mar; 20 Suppl:189S-195S. PMID: 1365424.
      Citations:    
    45. Mach RH, Jackson JR, Luedtke RR, Ivins KJ, Molinoff PB, Ehrenkaufer RL. Effect of N-alkylation on the affinities of analogues of spiperone for dopamine D2 and serotonin 5-HT2 receptors. J Med Chem. 1992 Feb 07; 35(3):423-30. PMID: 1531364.
      Citations:    
    46. Molinoff PB. Evolving properties of beta-adrenergic receptor antagonists. Pharmacotherapy. 1992; 12(2):144-53. PMID: 1349167.
      Citations:    
    47. Molinoff PB, Unsworth CD, Ferry RC, Hensler JG. Subtypes of serotonin receptors and anxiolytic drugs: model systems for the study of 5-HT receptors. Clin Neuropharmacol. 1992; 15 Suppl 1 Pt A:531A-532A. PMID: 1354062.
      Citations:    
    48. Szele FG, Artymyshyn R, Molinoff PB, Chesselet MF. Heterogeneous distribution of dopamine D2 receptor mRNA in the rat striatum: a quantitative analysis with in situ hybridization histochemistry. Anat Rec. 1991 Dec; 231(4):548-58. PMID: 1838906.
      Citations:    
    49. Marzo KP, Frey MJ, Wilson JR, Liang BT, Manning DR, Lanoce V, Molinoff PB. Beta-adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing. Circ Res. 1991 Dec; 69(6):1546-56. PMID: 1659503.
      Citations:    
    50. Williams K, Hanna JL, Molinoff PB. Developmental changes in the sensitivity of the N-methyl-D-aspartate receptor to polyamines. Mol Pharmacol. 1991 Nov; 40(5):774-82. PMID: 1682796.
      Citations:    
    51. Ebersole BJ, Molinoff PB. Inhibition of binding of [3H]PN200-110 to membranes from rat brain and heart by ascorbate is mediated by lipid peroxidation. J Pharmacol Exp Ther. 1991 Oct; 259(1):337-44. PMID: 1833526.
      Citations:    
    52. Ivins KJ, Molinoff PB. Desensitization and down-regulation of 5-HT2 receptors in P11 cells. J Pharmacol Exp Ther. 1991 Oct; 259(1):423-9. PMID: 1656028.
      Citations:    
    53. Romano C, Williams K, Molinoff PB. Polyamines modulate the binding of [3H]MK-801 to the solubilized N-methyl-D-aspartate receptor. J Neurochem. 1991 Sep; 57(3):811-8. PMID: 1830614.
      Citations:    
    54. Rao PA, Molinoff PB, Joyce JN. Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Brain Res Dev Brain Res. 1991 Jun 21; 60(2):161-77. PMID: 1832594.
      Citations:    
    55. Ivins KJ, Luedtke RR, Artymyshyn RP, Molinoff PB. Regulation of dopamine D2 receptors in a novel cell line (SUP1). Mol Pharmacol. 1991 Apr; 39(4):531-9. PMID: 1708089.
      Citations:    
    56. Williams K, Romano C, Dichter MA, Molinoff PB. Modulation of the NMDA receptor by polyamines. Life Sci. 1991; 48(6):469-98. PMID: 1825128.
      Citations:    
    57. Filtz TM, Chumpradit S, Kung HF, Molinoff PB. Synthesis and applications of an aldehyde-containing analogue of SCH-23390. Bioconjug Chem. 1990 Nov-Dec; 1(6):394-9. PMID: 2151561.
      Citations:    
    58. Williams K, Dawson VL, Romano C, Dichter MA, Molinoff PB. Characterization of polyamines having agonist, antagonist, and inverse agonist effects at the polyamine recognition site of the NMDA receptor. Neuron. 1990 Aug; 5(2):199-208. PMID: 2166545.
      Citations:    
    59. Luedtke RR, Bush M, Mach RH, Ehrenkaufer RE, Kung HF, Molinoff PB. Antibodies with high affinity for spiroperidol--II. Cross reactivity with iodobenzamide and domperidone. Mol Immunol. 1990 Jul; 27(7):667-77. PMID: 2395438.
      Citations:    
    60. Ivins KJ, Molinoff PB. Receptors for monoamines on cultured cells. Am J Hypertens. 1990 Jun; 3(6 Pt 2):43S-46S. PMID: 2166533.
      Citations:    
    61. Ivins KJ, Molinoff PB. Serotonin-2 receptors coupled to phosphoinositide hydrolysis in a clonal cell line. Mol Pharmacol. 1990 May; 37(5):622-30. PMID: 2160057.
      Citations:    
    62. Frey MJ, Lanoce V, Molinoff PB, Wilson JR. Skeletal muscle beta-receptors and isoproterenol-stimulated vasodilation in canine heart failure. J Appl Physiol (1985). 1989 Nov; 67(5):2026-31. PMID: 2557323.
      Citations:    
    63. Williams K, Romano C, Molinoff PB. Effects of polyamines on the binding of [3H]MK-801 to the N-methyl-D-aspartate receptor: pharmacological evidence for the existence of a polyamine recognition site. Mol Pharmacol. 1989 Oct; 36(4):575-81. PMID: 2554112.
      Citations:    
    64. van den Meiracker AH, Man in't Veld AJ, Boomsma F, Fischberg DJ, Molinoff PB, Schalekamp MA. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients. Circulation. 1989 Oct; 80(4):903-14. PMID: 2571431.
      Citations:    
    65. Barrett D, Breslau NA, Wax MB, Molinoff PB, Downs RW. New form of pseudohypoparathyroidism with abnormal catalytic adenylate cyclase. Am J Physiol. 1989 Aug; 257(2 Pt 1):E277-83. PMID: 2548394.
      Citations:    
    66. Romano C, Williams WV, Fischberg DJ, Cocero N, Weiner DB, Greene MI, Molinoff PB. Subtype-selective immunoprecipitation of the beta 2-adrenergic receptor. J Neurochem. 1989 Aug; 53(2):362-9. PMID: 2545815.
      Citations:    
    67. Schonwetter BS, Luedtke RR, Kung MP, Billings J, Kung HF, Molinoff PB. Characterization of membrane-bound and soluble D2 receptors in canine caudate using [125I]IBZM. J Pharmacol Exp Ther. 1989 Jul; 250(1):110-6. PMID: 2526213.
      Citations:    
    68. Johnson EW, Wolfe BB, Molinoff PB. Regulation of subtypes of beta-adrenergic receptors in rat brain following treatment with 6-hydroxydopamine. J Neurosci. 1989 Jul; 9(7):2297-305. PMID: 2568408.
      Citations:    
    69. Frey MJ, Mancini D, Fischberg D, Wilson JR, Molinoff PB. Effect of exercise duration on density and coupling of beta-adrenergic receptors on human mononuclear cells. J Appl Physiol (1985). 1989 Mar; 66(3):1494-500. PMID: 2540146.
      Citations:    
    70. Mancini DM, Frey MJ, Fischberg D, Molinoff PB, Wilson JR. Characterization of lymphocyte beta-adrenergic receptors at rest and during exercise in ambulatory patients with chronic congestive heart failure. Am J Cardiol. 1989 Feb 01; 63(5):307-12. PMID: 2536514.
      Citations:    
    71. McGonigle P, Boyson SJ, Reuter S, Molinoff PB. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors. Synapse. 1989; 3(1):74-82. PMID: 2521960.
      Citations:    
    72. Wax MB, Molinoff PB, Alvarado J, Polansky J. Characterization of beta-adrenergic receptors in cultured human trabecular cells and in human trabecular meshwork. Invest Ophthalmol Vis Sci. 1989 Jan; 30(1):51-7. PMID: 2536360.
      Citations:    
    73. Frey MJ, Molinoff PB. Mechanisms of downregulation of beta-adrenergic receptors: perspective on the role of beta-adrenergic receptors in congestive heart failure. J Cardiovasc Pharmacol. 1989; 14 Suppl 5:S13-8. PMID: 2478805.
      Citations:    
    74. Abramson SN, Martin MW, Hughes AR, Harden TK, Neve KA, Barrett DA, Molinoff PB. Interaction of beta-adrenergic receptors with the inhibitory guanine nucleotide-binding protein of adenylate cyclase in membranes prepared from cyc- S49 lymphoma cells. Biochem Pharmacol. 1988 Nov 15; 37(22):4289-97. PMID: 2848525.
      Citations:    
    75. Nicklaus KJ, McGonigle P, Molinoff PB. [3H]SCH 23390 labels both dopamine-1 and 5-hydroxytryptamine1c receptors in the choroid plexus. J Pharmacol Exp Ther. 1988 Oct; 247(1):343-8. PMID: 2971798.
      Citations:    
    76. Bode DC, Molinoff PB. Effects of ethanol in vitro on the beta adrenergic receptor-coupled adenylate cyclase system. J Pharmacol Exp Ther. 1988 Sep; 246(3):1040-7. PMID: 2843625.
      Citations:    
    77. Manik CP, Molinoff PB, McGonigle P. Comparison of 125I-SCH 23982 and [3H]SCH 23390 as ligands for the D-1 dopamine receptor. J Neurochem. 1988 Aug; 51(2):391-7. PMID: 3292702.
      Citations:    
    78. Bode DC, Molinoff PB. Effects of chronic exposure to ethanol on the physical and functional properties of the plasma membrane of S49 lymphoma cells. Biochemistry. 1988 Jul 26; 27(15):5700-7. PMID: 2846048.
      Citations:    
    79. McGonigle P, Wax MB, Molinoff PB. Characterization of binding sites for 3H-spiroperidol in human retina. Invest Ophthalmol Vis Sci. 1988 May; 29(5):687-94. PMID: 2452802.
      Citations:    
    80. van den Meiracker AH, Man in 't Veld AJ, Fischberg DJ, Molinoff PB, van Eck HJ, Boomsma F, Derkx FH, Schalekamp MA. Acute and long-term effects of acebutolol on systemic and renal hemodynamics, body fluid volumes, catecholamines, active renin, aldosterone, and lymphocyte beta-adrenoceptor density. J Cardiovasc Pharmacol. 1988 Apr; 11(4):413-23. PMID: 2453744.
      Citations:    
    81. Luedtke RR, Korner M, Neve KA, Molinoff PB. Monoclonal antibodies with high affinity for spiroperidol. J Neurochem. 1988 Apr; 50(4):1253-62. PMID: 2964511.
      Citations:    
    82. Boyson SJ, McGonigle P, Luthin GR, Wolfe BB, Molinoff PB. Effects of chronic administration of neuroleptic and anticholinergic agents on densities of D2 dopamine and muscarinic cholinergic receptors in rat striatum. J Pharmacol Exp Ther. 1988 Mar; 244(3):987-93. PMID: 2908050.
      Citations:    
    83. Ebersole BJ, Gajary ZL, Molinoff PB. Endogenous modulators of binding of [3H]nitrendipine in extracts of rat brain. J Pharmacol Exp Ther. 1988 Mar; 244(3):971-6. PMID: 3252044.
      Citations:    
    84. Luedtke RR, Molinoff PB. Characterization of binding sites for [3H]spiroperidol. Biochem Pharmacol. 1987 Oct 01; 36(19):3255-64. PMID: 2959288.
      Citations:    
    85. Lin C, McGonigle P, Molinoff PB. Characterization of D-2 dopamine receptors in a tumor of the rat anterior pituitary gland. J Pharmacol Exp Ther. 1987 Sep; 242(3):950-6. PMID: 2958621.
      Citations:    
    86. Abramson SN, Shorr RG, Molinoff PB. Interactions of beta-adrenergic receptors with a membrane protein other than the stimulatory guanine nucleotide-binding protein. Biochem Pharmacol. 1987 Jul 15; 36(14):2263-9. PMID: 3038120.
      Citations:    
    87. Wax MB, Molinoff PB. Distribution and properties of beta-adrenergic receptors in human iris-ciliary body. Invest Ophthalmol Vis Sci. 1987 Mar; 28(3):420-30. PMID: 3030954.
      Citations:    
    88. Abramson SN, McGonigle P, Molinoff PB. Evaluation of models for analysis of radioligand binding data. Mol Pharmacol. 1987 Jan; 31(1):103-11. PMID: 3027522.
      Citations:    
    89. Reynolds EE, Molinoff PB. Down regulation of beta adrenergic receptors in S49 lymphoma cells induced by atypical agonists. J Pharmacol Exp Ther. 1986 Dec; 239(3):654-60. PMID: 2879029.
      Citations:    
    90. Boyson SJ, McGonigle P, Molinoff PB. Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J Neurosci. 1986 Nov; 6(11):3177-88. PMID: 3534157.
      Citations:    
    91. McGonigle P, Neve KA, Molinoff PB. A quantitative method of analyzing the interaction of slightly selective radioligands with multiple receptor subtypes. Mol Pharmacol. 1986 Oct; 30(4):329-37. PMID: 2876374.
      Citations:    
    92. Contreras ML, Wolfe BB, Molinoff PB. Kinetic analysis of the interactions of agonists and antagonists with beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Oct; 239(1):136-43. PMID: 2876092.
      Citations:    
    93. Hedberg A, Gerber JG, Nies AS, Wolfe BB, Molinoff PB. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes. J Pharmacol Exp Ther. 1986 Oct; 239(1):117-23. PMID: 3020227.
      Citations:    
    94. Liang BT, Molinoff PB. Beta adrenergic receptor subtypes in the atria: evidence for close coupling of beta-1 and beta-2 adrenergic receptors to adenylate cyclase. J Pharmacol Exp Ther. 1986 Sep; 238(3):886-92. PMID: 2875173.
      Citations:    
    95. Neve KA, Molinoff PB. Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade. Mol Pharmacol. 1986 Aug; 30(2):104-11. PMID: 3016496.
      Citations:    
    96. Rabin RA, Bode DC, Molinoff PB. Relationship between ethanol-induced alterations in fluorescence anisotropy and adenylate cyclase activity. Biochem Pharmacol. 1986 Jul 15; 35(14):2331-5. PMID: 3729989.
      Citations:    
    97. Neve KA, McGonigle P, Molinoff PB. Quantitative analysis of the selectivity of radioligands for subtypes of beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Jul; 238(1):46-53. PMID: 3014123.
      Citations:    
    98. Neve KA, Molinoff PB. Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptors. Am J Cardiol. 1986 Apr 25; 57(12):17F-22F. PMID: 2871741.
      Citations:    
    99. Contreras ML, Wolfe BB, Molinoff PB. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. II. Agonist binding to soluble beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Apr; 237(1):165-72. PMID: 2870175.
      Citations:    
    100. Contreras ML, Wolfe BB, Molinoff PB. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. I. High- and low-affinity states of agonist binding to membrane-bound beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Apr; 237(1):154-64. PMID: 2870174.
      Citations:    
    101. Severson JA, Pittman RN, Gal J, Molinoff PB, Finch CE. Genetic influence on the regulation of beta adrenergic receptors in mice. J Pharmacol Exp Ther. 1986 Jan; 236(1):24-9. PMID: 3001288.
      Citations:    
    102. Romano C, Molinoff PB. Adenylate kinase increases adenylate cyclase activity in membranes from rat lung. J Cyclic Nucleotide Protein Phosphor Res. 1986; 11(1):63-73. PMID: 3009572.
      Citations:    
    103. Neve KA, Barrett DA, Molinoff PB. Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists. J Pharmacol Exp Ther. 1985 Dec; 235(3):657-64. PMID: 2867205.
      Citations:    
    104. Abramson SN, Molinoff PB. Properties of beta-adrenergic receptors of cultured mammalian cells. Interaction of receptors with a guanine nucleotide-binding protein in membranes prepared from L6 myoblasts and from wild-type and cyc- S49 lymphoma cells. J Biol Chem. 1985 Nov 25; 260(27):14580-8. PMID: 2997214.
      Citations:    
    105. Hedberg A, Kempf F, Josephson ME, Molinoff PB. Coexistence of beta-1 and beta-2 adrenergic receptors in the human heart: effects of treatment with receptor antagonists or calcium entry blockers. J Pharmacol Exp Ther. 1985 Sep; 234(3):561-8. PMID: 2863366.
      Citations:    
    106. Liang BT, Frame LH, Molinoff PB. Beta 2-adrenergic receptors contribute to catecholamine-stimulated shortening of action potential duration in dog atrial muscle. Proc Natl Acad Sci U S A. 1985 Jul; 82(13):4521-5. PMID: 2989829.
      Citations:    
    107. Rabin RA, Bode DC, Molinoff PB. Differential effects of cytosolic modulators of fluoride-stimulated adenylate cyclase activity in striatum and cerebral cortex. Alcohol Drug Res. 1985-1986; 6(6):379-86. PMID: 3836685.
      Citations:    
    108. Abramson SN, Reynolds EE, Hoyer D, Molinoff PB. Interactions of agonists with beta-adrenergic receptors on S49 lymphoma cells. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1985; 19:13-27. PMID: 2860777.
      Citations:    
    109. Huff RM, Molinoff PB. Assay of dopamine receptors with [alpha-3H]flupenthixol. J Pharmacol Exp Ther. 1985 Jan; 232(1):57-61. PMID: 3965700.
      Citations:    
    110. Pittman RN, Rabin RA, Molinoff PB. Desensitization of beta-adrenergic receptor-coupled adenylate cyclase activity. Differences following exposure of cells to two full agonists. Biochem Pharmacol. 1984 Nov 15; 33(22):3579-84. PMID: 6150707.
      Citations:    
    111. Pittman RN, Reynolds EE, Molinoff PB. Relationship between intrinsic activities of agonists in normal and desensitized tissue and agonist-induced loss of beta adrenergic receptors. J Pharmacol Exp Ther. 1984 Sep; 230(3):614-8. PMID: 6147404.
      Citations:    
    112. Abramson SN, Molinoff PB. In vitro interactions of agonists and antagonists with beta-adrenergic receptors. Biochem Pharmacol. 1984 Mar 15; 33(6):869-75. PMID: 6143559.
      Citations:    
    113. Hoyer D, Reynolds EE, Molinoff PB. Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists. Mol Pharmacol. 1984 Mar; 25(2):209-18. PMID: 6142414.
      Citations:    
    114. Molinoff PB. Alpha- and beta-adrenergic receptor subtypes properties, distribution and regulation. Drugs. 1984; 28 Suppl 2:1-15. PMID: 6098436.
      Citations:    
    115. McGonigle P, Huff RM, Molinoff PB. A comprehensive method for the quantitative determination of dopamine receptor subtypes. Ann N Y Acad Sci. 1984; 430:77-90. PMID: 6331265.
      Citations:    
    116. Rabin RA, Molinoff PB. Multiple sites of action of ethanol on adenylate cyclase. J Pharmacol Exp Ther. 1983 Dec; 227(3):551-6. PMID: 6606704.
      Citations:    
    117. Pittman RN, Molinoff PB. Interactions of full and partial agonists with beta-adrenergic receptors on intact L6 muscle cells. Mol Pharmacol. 1983 Nov; 24(3):398-408. PMID: 6138704.
      Citations:    
    118. Zahniser NR, Molinoff PB. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum. Mol Pharmacol. 1983 Mar; 23(2):303-9. PMID: 6835199.
      Citations:    
    119. Molinoff PB, Aarons RD. Effects of drugs on beta-adrenergic receptors on human lymphocytes. J Cardiovasc Pharmacol. 1983; 5 Suppl 1:S63-7. PMID: 6188922.
      Citations:    
    120. Aarons RD, Nies AS, Gerber JG, Molinoff PB. Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists. J Pharmacol Exp Ther. 1983 Jan; 224(1):1-6. PMID: 6129315.
      Citations:    
    121. Minneman KP, Wolfe BB, Pittman RN, Molinoff PB. beta-Adrenergic receptor subtypes in rat brain. Adv Biochem Psychopharmacol. 1983; 36:73-81. PMID: 6305157.
      Citations:    
    122. Minneman KP, Wolfe BB, Molinoff PB. Selective changes in the density of beta 1-adrenergic receptors in rat striatum following chronic drug treatment and adrenalectomy. Brain Res. 1982 Dec 09; 252(2):309-14. PMID: 6295545.
      Citations:    
    123. Huff RM, Molinoff PB. Quantitative determination of dopamine receptor subtypes not linked to activation of adenylate cyclase in rat striatum. Proc Natl Acad Sci U S A. 1982 Dec; 79(23):7561-5. PMID: 6961433.
      Citations:    
    124. Aarons RD, Molinoff PB. Changes in the density of beta adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol. J Pharmacol Exp Ther. 1982 May; 221(2):439-43. PMID: 6281414.
      Citations:    
    125. Wolfe BB, Minneman KP, Molinoff PB. Selective increases in the density of cerebellar beta-1-adrenergic receptors. Brain Res. 1982 Feb 25; 234(2):474-9. PMID: 6277437.
      Citations:    
    126. Heidenreich KA, Weiland GA, Molinoff PB. Effects of magnesium and N-ethylmaleimide on the binding of 3H-hydroxybenzylisoproterenol to beta-adrenergic receptors. J Biol Chem. 1982 Jan 25; 257(2):804-10. PMID: 6274864.
      Citations:    
    127. Molinoff PB, Aarons RD, Nies AS, Gerber JG, Wolfe BB, Goens MB. Effects of pindolol and propranolol on beta-adrenergic receptors on human lymphocytes. Br J Clin Pharmacol. 1982; 13(Suppl 2):365S. PMID: 6285945.
      Citations:    
    128. Molinoff PB, Wolfe BB, Weiland GA. Quantitative analysis of drug-receptor interactions: II. Determination of the properties of receptor subtypes. Life Sci. 1981 Aug 03; 29(5):427-43. PMID: 6116137.
      Citations:    
    129. Weiland GA, Molinoff PB. Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties. Life Sci. 1981 Jul 27; 29(4):313-30. PMID: 6116136.
      Citations:    
    130. Staunton DA, Wolfe BB, Groves PM, Molinoff PB. Dopamine receptor changes following destruction of the nigrostriatal pathway: lack of a relationship to rotational behavior. Brain Res. 1981 May 04; 211(2):315-27. PMID: 7237126.
      Citations:    
    131. Zahniser NR, Heidenreich KA, Molinoff PB. Binding of [3H]amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat striatal membranes. Effects of purine nucleotides and ultraviolet irradiation. Mol Pharmacol. 1981 May; 19(3):372-8. PMID: 7266464.
      Citations:    
    132. Minneman KP, Pittman RN, Yeh HH, Woodward DJ, Wolfe BB, Molinoff PB. Selective survival of beta 1-adenergic receptors in rat cerebellum following neonatal x-irradiation. Brain Res. 1981 Mar 23; 209(1):25-34. PMID: 6260307.
      Citations:    
    133. Wolfe BB, Augustyn DH, Majocha RE, Dibner MD, Molinoff PB, Baldessarini RJ, Walton KG. Effects of isoproterenol on the development of beta-adrenergic receptors in brain cell aggregates. Brain Res. 1981 Feb 23; 207(1):174-7. PMID: 6258728.
      Citations:    
    134. Voelkel NF, Hegstrand L, Reeves JT, McMurty IF, Molinoff PB. Effects of hypoxia on density of beta-adrenergic receptors. J Appl Physiol Respir Environ Exerc Physiol. 1981 Feb; 50(2):363-6. PMID: 6259101.
      Citations:    
    135. Rabin RA, Molinoff PB. Activation of adenylate cyclase by ethanol in mouse striatal tissue. J Pharmacol Exp Ther. 1981 Jan; 216(1):129-34. PMID: 7452500.
      Citations:    
    136. Molinoff PB, Weiland GA, Heidenreich KA, Pittman RN, Minneman KP. Interactions of agonists and antagonists with beta-adrenergic receptors. Adv Cyclic Nucleotide Res. 1981; 14:51-67. PMID: 6116391.
      Citations:    
    137. Minneman KP, Pittman RN, Molinoff PB. Beta-adrenergic receptor subtypes: properties, distribution, and regulation. Annu Rev Neurosci. 1981; 4:419-61. PMID: 6111980.
      Citations:    
    138. Weiland GA, Minneman KP, Molinoff PB. Thermodynamics of agonist and antagonist interactions with mammalian beta-adrenergic receptors. Mol Pharmacol. 1980 Nov; 18(3):341-7. PMID: 6110167.
      Citations:    
    139. Pittman RN, Minneman KP, Molinoff PB. Alterations in beta 1- and beta 2-adrenergic receptor density in the cerebellum of aging rats. J Neurochem. 1980 Jul; 35(1):273-5. PMID: 6256478.
      Citations:    
    140. Rabin RA, Wolfe BB, Dibner MD, Zahniser NR, Melchior C, Molinoff PB. Effects of ethanol administration and withdrawal on neurotransmitter receptor systems in C57 mice. J Pharmacol Exp Ther. 1980 Jun; 213(3):491-6. PMID: 6259318.
      Citations:    
    141. Minneman KP, Molinoff PB. Classification and quantitation of beta-adrenergic receptor subtypes. Biochem Pharmacol. 1980 May 15; 29(10):1317-23. PMID: 6249311.
      Citations:    
    142. Aarons RD, Nies AS, Gal J, Hegstrand LR, Molinoff PB. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. J Clin Invest. 1980 May; 65(5):949-57. PMID: 6102572.
      Citations:    
    143. Pittman RN, Minneman KP, Molinoff PB. Ontogeny of beta 1- and beta 2-adrenergic receptors in rat cerebellum and cerebral cortex. Brain Res. 1980 Apr 28; 188(2):357-68. PMID: 6245756.
      Citations:    
    144. Dibner MD, Zahniser NR, Wolfe BB, Rabin RA, Molinoff PB. Brain neurotransmitter receptor systems in mice genetically selected for differences in sensitivity to ethanol. Pharmacol Biochem Behav. 1980 Apr; 12(4):509-13. PMID: 6104820.
      Citations:    
    145. Hedberg A, Minneman KP, Molinoff PB. Differential distribution of beta-1 and beta-2 adrenergic receptors in cat and guinea-pig heart. J Pharmacol Exp Ther. 1980 Mar; 212(3):503-8. PMID: 6244386.
      Citations:    
    146. Rabin RA, Molinoff PB. Brain neurotransmitter receptor systems in alcohol treated mice and in mice genetically selected for differences in sensitivity to alcohol. Adv Exp Med Biol. 1980; 132:787-95. PMID: 6107001.
      Citations:    
    147. Minneman KP, Weiland GA, Molinoff PB. A comparison of the beta-adrenergic receptor of the turkey erythrocyte with mammalian beta1 and beta2 receptors. Mol Pharmacol. 1980 Jan; 17(1):1-7. PMID: 6247636.
      Citations:    
    148. Pittman RN, Molinoff PB. Interactions of agonists and antagonists with beta-adrenergic receptors on intact L6 muscle cells. J Cyclic Nucleotide Res. 1980; 6(6):421-35. PMID: 6260844.
      Citations:    
    149. Heidenreich KA, Weiland GA, Molinoff PB. Characterization of radiolabeled agonist binding to beta-adrenergic receptors in mammalian tissues. J Cyclic Nucleotide Res. 1980; 6(3):217-30. PMID: 6108337.
      Citations:    
    150. Zahniser NR, Minneman KP, Molinoff PB. Persistence of beta-adrenergic receptors in rat striatum following kainic acid administration. Brain Res. 1979 Dec 14; 178(2-3):589-95. PMID: 228797.
      Citations:    
    151. Miller TR, Handelman WA, Arnold PE, McDonald KM, Molinoff PB, Schrier RW. Effect of central catecholamine depletion on the osmotic and nonosmotic stimulation of vasopressin (antidiuretic hormone) in the rat. J Clin Invest. 1979 Dec; 64(6):1599-607. PMID: 500827.
      Citations:    
    152. Minneman KP, Hedberg A, Molinoff PB. Comparison of beta adrenergic receptor subtypes in mammalian tissues. J Pharmacol Exp Ther. 1979 Dec; 211(3):502-8. PMID: 229209.
      Citations:    
    153. Sinensky M, Minneman KP, Molinoff PB. Increased membrane acyl chain ordering activates adenylate cyclase. J Biol Chem. 1979 Sep 25; 254(18):9135-41. PMID: 479183.
      Citations:    
    154. Weiland GA, Minneman KP, Molinoff PB. Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor. Nature. 1979 Sep 13; 281(5727):114-7. PMID: 38405.
      Citations:    
    155. Dibner MD, Molinoff PB. Agonist-induced changes in beta adrenergic receptor density and receptor-mediated responsiveness in slices of rat cerebral cortex. J Pharmacol Exp Ther. 1979 Sep; 210(3):433-9. PMID: 39161.
      Citations:    
    156. Hegstrand LR, Minneman KP, Molinoff PB. Multiple effects of guanosine triphosphate on beta adrenergic receptors and adenylate cyclase activity in rat heart, lung and brain. J Pharmacol Exp Ther. 1979 Aug; 210(2):215-21. PMID: 222893.
      Citations:    
    157. Hedberg A, Minneman KP, Molinoff PB. Regional distribution of beta 1- and beta 2-adrenoceptors in the right atrium and left ventricle of the cat and guinea pig heart [proceedings]. Br J Pharmacol. 1979 Jul; 66(3):505P. PMID: 230883.
      Citations:    
    158. Minneman KP, Hegstrand LR, Molinoff PB. The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro. Mol Pharmacol. 1979 Jul; 16(1):21-33. PMID: 39243.
      Citations:    
    159. Minneman KP, Hegstrand LR, Molinoff PB. Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes. Mol Pharmacol. 1979 Jul; 16(1):34-46. PMID: 39246.
      Citations:    
    160. Minneman KP, Dibner MD, Wolfe BB, Molinoff PB. beta1- and beta2-Adrenergic receptors in rat cerebral cortex are independently regulated. Science. 1979 May 25; 204(4395):866-8. PMID: 35829.
      Citations:    
    161. Aarons RD, Nies AS, Gal J, Molinoff PB. Increased human lymphocyte beta-adrenergic receptor density following chronic propranolol treatment. Proc West Pharmacol Soc. 1979; 22:175-6. PMID: 229487.
      Citations:    
    162. Wolfe BB, Harden TK, Sporn JR, Molinoff PB. Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants. J Pharmacol Exp Ther. 1978 Nov; 207(2):446-57. PMID: 213556.
      Citations:    
    163. Zahniser NR, Molinoff PB. Effect of guanine nucleotides on striatal dopamine receptors. Nature. 1978 Oct 05; 275(5679):453-5. PMID: 692725.
      Citations:    
    164. Nelson DL, Harden TK, Molinoff PB. Adrenergic storage vesicles in rat heart: quantitation of membrane-bound and membrane-enclosed dopamine beta-hydroxylase. J Pharmacol Exp Ther. 1978 May; 205(2):357-65. PMID: 641833.
      Citations:    
    165. Johnson GL, Wolfe BB, Harden TK, Molinoff PB, Perkins JP. Role of beta-adrenergic receptors in catecholamine-induced desensitization of adenylate cyclase in human astrocytoma cells. J Biol Chem. 1978 Mar 10; 253(5):1472-80. PMID: 203594.
      Citations:    
    166. Molinoff PB, Sporn JR, Wolfe BB, Harden TK. Regulation of beta-adrenergic receptors in the cerebral cortex. Adv Cyclic Nucleotide Res. 1978; 9:465-83. PMID: 208390.
      Citations:    
    167. Sporn JR, Wolfe BB, Harden TK, Molinoff PB. Supersensitivity in rat cerebral cortex: pre- and postsynaptic effects of 6-hydroxydopamine at noradrenergic synapses. Mol Pharmacol. 1977 Nov; 13(6):1170-80. PMID: 201833.
      Citations:    
    168. Henrich WL, Katz FH, Molinoff PB, Schrier RW. Competitive effects of hypokalemia and volume depletion on plasma renin activity, aldosterone and catecholamine concentrations in hemodialysis patients. Kidney Int. 1977 Oct; 12(4):279-84. PMID: 599838.
      Citations:    
    169. Harden TK, Wolfe BB, Sporn JR, Poulos BK, Molinoff PB. Effects of 6-hydroxydopamine on the development of the beta adrenergic receptor/adenylate cyclase system in rat cerebral cortex. J Pharmacol Exp Ther. 1977 Oct; 203(1):132-43. PMID: 198523.
      Citations:    
    170. Arnold EB, Molinoff PB, Rutledge CO. The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine. J Pharmacol Exp Ther. 1977 Sep; 202(3):544-57. PMID: 894521.
      Citations:    
    171. Orcutt JC, Molinoff PB. Endogenous inhibitors of dopamine beta-hydroxylase: separation of multiple forms and access to the enzyme. J Pharmacol Exp Ther. 1977 Sep; 202(3):590-600. PMID: 894523.
      Citations:    
    172. Harden TK, Wolfe BB, Sporn JR, Perkins JP, Molinoff PB. Ontogeny of beta-adrenergic receptors in rat cerebral cortex. Brain Res. 1977 Apr 08; 125(1):99-108. PMID: 192417.
      Citations:    
    173. Molinoff PB. Octopamine: normal occurrence in central and peripheral nerves of rats. Psychopharmacol Bull. 1976 Oct; 12(4):32-4. PMID: 788019.
      Citations:    
    174. Nelson DL, Molinoff PB. Differential effects of nerve impulses on adrenergic storage vesicles in rat heart. J Pharmacol Exp Ther. 1976 Jul; 198(1):112-22. PMID: 933001.
      Citations:    
    175. Orcutt JC, Molinoff PB. Endogenous inhibitors of dopamine-beta- hydroxylase in rat organs. Biochem Pharmacol. 1976 May 15; 25(10):1167-74. PMID: 938540.
      Citations:    
    176. Nelson DL, Molinoff PB. Distribution and properties of adrenergic storage vesicles in nerve terminals. J Pharmacol Exp Ther. 1976 Feb; 196(2):346-59. PMID: 1255482.
      Citations:    
    177. Murphy DL, Cahan DH, Molinoff PB. Occurrence, transport, and storage of octopamine in human thrombocytes. Clin Pharmacol Ther. 1975 Nov; 18(5 Pt 1):587-93. PMID: 1102236.
      Citations:    
    178. Molinoff PB, Nelson DL, Orcutt JC. Proceedings: Dopamine-beta-hydroxylase and the regulation of the noradrenergic neuron. Psychopharmacol Bull. 1974 Jul; 10(3):24-5. PMID: 4419356.
      Citations:    
    179. Juorio AV, Molinoff PB. The normal occurrence of octopamine in neural tissue of the Octopus and other cephalopods. J Neurochem. 1974 Feb; 22(2):271-80. PMID: 4598025.
      Citations:    
    180. Molinoff PB. The regulation of the noradrenergic neuron. J Psychiatr Res. 1974; 11:339-45. PMID: 4156788.
      Citations:    
    181. Molinoff PB, Nelson DL, Orcutt JC. Dopamine-beta-hydroxylase and the regulation of the noradrenergic neuron. Adv Biochem Psychopharmacol. 1974; 12(0):95-104. PMID: 4153879.
      Citations:    
    182. Molinoff PB. Cholinergic receptors in Torpedo. Neurosci Res Program Bull. 1973 Jun; 11(3):253-7. PMID: 4716597.
      Citations:    
    183. Molinoff PB, Brimijoin S, Axelrod J. Induction of dopamine- -hydroxylase and tyrosine hydroxylase in rat hearts and sympathetic ganglia. J Pharmacol Exp Ther. 1972 Jul; 182(1):116-29. PMID: 5041648.
      Citations:    
    184. Barker DL, Molinoff PB, Kravitz EA. Octopamine in the lobster nervous system. Nat New Biol. 1972 Mar 15; 236(63):61-3. PMID: 4553466.
      Citations:    
    185. Silberstein SD, Brimijoin S, Molinoff PB, Lemberger L. Induction of dopamine- -hydroxylase in rat superior cervical ganglia in organ culture. J Neurochem. 1972 Mar; 19(3):919-21. PMID: 5030996.
      Citations:    
    186. Molinoff PB, Potter LT. Isolation of the cholinergic receptor protein of Torpedo electric tissue. Adv Biochem Psychopharmacol. 1972; 6:111-34. PMID: 4341331.
      Citations:    
    187. Molinoff PB, Axelrod J. Distribution and turnover of octopamine in tissues. J Neurochem. 1972 Jan; 19(1):157-63. PMID: 4333325.
      Citations:    
    188. Reis DJ, Molinoff PB. Brain dopamine- -hydroxylase: regional distribution and effects of lesions and 6-hydroxy-dopamine on activity. J Neurochem. 1972 Jan; 19(1):195-204. PMID: 5009896.
      Citations:    
    189. Ross SB, Weinshilboum R, Molinoff PB, Vesell ES, Axelrod J. Electrophoretic properties of dopamine -hydroxylase in several tissues from three species. Mol Pharmacol. 1972 Jan; 8(1):50-8. PMID: 5061518.
      Citations:    
    190. Juorio AV, Molinoff PB. Distribution of octopamine in nervous tissues of Octopus vulgaris. Br J Pharmacol. 1971 Oct; 43(2):438P-439P. PMID: 4945729.
      Citations:    
    191. Brimijoin S, Molinoff PB. Effects of 6-hydroxydopamine on the activity of tyrosine hydroxylase and dopamine- -hydroxylase in sympathetic ganglia of the rat. J Pharmacol Exp Ther. 1971 Sep; 178(3):417-24. PMID: 4105924.
      Citations:    
    192. Molinoff PB, Weinshilboum R, Axelrod J. A sensitive enzymatic assay for dopamine- -hydroxylase. J Pharmacol Exp Ther. 1971 Sep; 178(3):425-31. PMID: 5571894.
      Citations:    
    193. Molinoff PB, Brimijoin S, Axelrod J. Trans-synaptic induction of dopamine (3,4-dihydroxyphenethylamine) -hydroxylase in adrenergic tissues of the rat. Biochem J. 1971 Jul; 123(4):32P-33P. PMID: 4399553.
      Citations:    
    194. Miledi R, Molinoff P, Potter LT. Isolation of the cholinergic receptor protein of Torpedo electric tissue. Nature. 1971 Feb 19; 229(5286):554-7. PMID: 4925349.
      Citations:    
    195. Molinoff PB, Axelrod J. Biochemistry of catecholamines. Annu Rev Biochem. 1971; 40:465-500. PMID: 4399447.
      Citations:    
    196. Molinoff PB, Brimijoin S, Weinshilboum R, Axelrod J. Neurally mediated increase in dopamine-beta-hydroxylase activity. Proc Natl Acad Sci U S A. 1970 Jun; 66(2):453-8. PMID: 4317916.
      Citations:    
    197. Molinoff PB, Landsberg L, Axelrod J. An enzymatic assay for octopamine and other beta-hydroxylated phenylethylamines. J Pharmacol Exp Ther. 1969 Dec; 170(2):253-61. PMID: 4901590.
      Citations:    
    198. Molinoff P, Axelrod J. Octopamine: normal occurrence in sympathetic nerves of rats. Science. 1969 Apr 25; 164(3878):428-9. PMID: 4887742.
      Citations:    
    199. Molinoff PB, Kravitz EA. The metabolism of gamma-aminobutyric acid (GABA) in the lobster nervous system--glutamic decarboxylase. J Neurochem. 1968 May; 15(5):391-409. PMID: 5648485.
      Citations:    
    200. Kravitz EA, Molinoff PB, Hall ZW. A comparison of the enzymes and substrates of gamma-aminobutyric acid metabolism in lobster excitatory and inhibitory axons. Proc Natl Acad Sci U S A. 1965 Sep; 54(3):778-82. PMID: 5217457.
      Citations:    
    Molinoff's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (632)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _